Why Drug Companies Are Rushing to Market Ketamine Medicines

New York Times - Oct 20, 2026

Spurred on by the Trump administration’s embrace of psychedelic medicine, researchers are experimenting with new — and not so new — forms of the anesthetic.

Read full article

More News

About Us
Logo

In-Depth Science delivers comprehensive and compelling news and analysis on everything science and technology, seven days a week in a reader-friendly format.

Contact us: sales[at]indepthscience.com

Copyright © 2015 - 2026 In-Depth Science. All Rights Reserved.